Table 2.

Clinicopathologic Features of BRCA-Mutated and Wild-Type Patients

Variable	BRCA (n = 22)	Wild-type (n = 105)	p value
Operation procedure, n (%)			0.950
Pancreaticoduodenectomy	20 (91)	95 (90)
Distal pancreatectomy	2 (9)	10 (10)
Tumor size, cm, median (IQR)	3 (2.5–3.7)	3 (2.3–3.5)	0.987
Lymph nodes, median (IQR)	20 (13–23)	18 (14–26)	0.674
Positive nodal metastases, n (%)	14 (64)	76 (72)	0.412
Grade, n (%)			0.202
1	0 (0)	7 (7)
2	14 (64)	47 (46)
3	8 (36)	49 (48)
T-stage, n (%)			0.799
T1	2 (9)	8 (8)
T2	5 (23)	31 (30)
T3	15 (68)	64 (61)
T4	0 (0)	2 (2)
Perivascular invasion, n (%)			0.599
Yes	7 (32)	55 (52)
No	8 (36)	47 (45)
Perineural invasion, n (%)			0.937
Yes	19 (86)	90 (86)
No	3 (14)	15 (14)
Resection margin, n (%)			0.577
R0	17 (77)	75 (71)
R1	5 (23)	30 (29)

IQR, interquartile range.